MRNA: Moderna, Inc. Stock

by  •  • Comments Off on MRNA: Moderna, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 46,142.06
Enterprise Value ($M) 44,091.06
Book Value ($M) 12,817.00
Book Value / Share 33.44
Price / Book 3.60
NCAV ($M) 5,688.00
NCAV / Share 14.84
Price / NCAV 8.11

Profitability (mra)
Return on Invested Capital (ROIC) -0.42
Return on Assets (ROA) -0.27
Return on Equity (ROE) -0.35

Liquidity (mrq)
Quick Ratio 3.91
Current Ratio 4.03

Balance Sheet (mrq) ($M)
Current Assets 9,600.00
Assets 16,729.00
Liabilities 3,912.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 6,848.00
Operating Income -4,239.00
Net Income -4,714.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -3,118.00
Cash from Investing 4,206.00
Cash from Financing -1,377.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-10 13G/A Vanguard Group Inc 10.20 15.13
02-07 13G/A Bancel Stephane 7.80 4.23
01-29 13G/A BlackRock Inc. 6.60 -3.12
01-29 13G/A Baillie Gifford & Co 11.97 1.94

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-02-23 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K
2023-11-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-07-26 394,664 1,567,372 25.18
2024-07-25 540,266 2,139,002 25.26
2024-07-24 618,481 2,573,535 24.03
2024-07-23 296,905 1,353,169 21.94
2024-07-22 315,453 1,318,681 23.92

(click for more detail)

Similar Companies
MIST – Milestone Pharmaceuticals Inc. MLYS – Mineralys Therapeutics, Inc.
MNMD – Mind Medicine (MindMed) Inc. MRSN – Mersana Therapeutics, Inc.
MRVI – Maravai LifeSciences Holdings, Inc.


Financial data and stock pages provided by
Fintel.io